The choice of the medicine phosphodiesterase inhibitors of 5th type for treating patients with erectile dysfunction and chronic prostatitis
The study of the genital system' vessels in patients with erectile disfunction and chronic prostatitis was accomplished using ultrasound Dopplerography and pharmacological testing by phosphodiesterase inhibitors of 5th type (PDEI-5). The positive impact of PDEI-5 (such as Sildenafil, Vardenafil...
Saved in:
| Main Authors: | P. V. Glybochko, Yu. G. Alyaev, Yu. M. Esilevskiy, A. A. Kamalov, Yu. L. Demidko, D. N. Fiev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2013-06-01
|
| Series: | Сеченовский вестник |
| Subjects: | |
| Online Access: | https://www.sechenovmedj.com/jour/article/view/781 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Membrane-Mediated Action of Phosphodiesterase 5 Inhibitors
by: Anna I. Malykhina, et al.
Published: (2025-04-01) -
Phosphodiesterase-5 inhibitors: Raynaud's and beyond
by: Sanat Phatak, et al.
Published: (2017-01-01) -
PREVENTION AND TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS AFTER RADICAL NERVESPARING PROSTATECTOMY
by: P. A. Karnaukh, et al.
Published: (2015-12-01) -
Predictive value of systemic inflammatory response index in patients with erectile dysfunction on tadalafil unresponsive patients
by: Resul Sobay
Published: (2025-12-01) -
PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
by: A. A. Kamalov, et al.
Published: (2018-03-01)